Articles with "minimal measurable" as a keyword



Peripheral blood minimal/measurable residual disease assessed in flow cytometry in acute myeloblastic leukemia

Sign Up to like & get
recommendations!
Published in 2019 at "Leukemia"

DOI: 10.1038/s41375-019-0393-0

Abstract: There are unsolved questions in the field of minimal/ measurable residual disease (MRD) detection by multiparameter flow cytometry (MFC) in acute myeloblastic leukemia (AML). One of them, the value of peripheral blood (PB) testing, is… read more here.

Keywords: mrd; measurable residual; minimal measurable; residual disease ... See more keywords
Photo by emileseguin from unsplash

How I Diagnose Minimal/Measurable Residual Disease in B Lymphoblastic Leukemia/Lymphoma by Flow Cytometry.

Sign Up to like & get
recommendations!
Published in 2020 at "American journal of clinical pathology"

DOI: 10.1093/ajcp/aqaa242

Abstract: OBJECTIVES Assessment for minimal/measurable residual disease (MRD) is a powerful prognostic factor in B lymphoblastic leukemia/lymphoma (B-LL/L) that is quickly becoming standard of care in assessing patients with B-LL/L posttherapy. MRD can be assessed using… read more here.

Keywords: cytometry; measurable residual; minimal measurable; flow cytometry ... See more keywords

Using minimal (measurable) residual disease assessments to guide decision-making for timing of allogeneic transplantation in acute myeloid leukemia.

Sign Up to like & get
recommendations!
Published in 2019 at "Current Opinion in Hematology"

DOI: 10.1097/moh.0000000000000543

Abstract: PURPOSE OF REVIEW The current review aims to highlight recent and important developments in the detection and value of minimal (measurable) residual disease (MRD) testing in patients with acute myeloid leukemia (AML) and the impact… read more here.

Keywords: acute myeloid; residual disease; measurable residual; timing allogeneic ... See more keywords

Multicentric standardization of minimal/measurable residual disease in B‐cell precursor acute lymphoblastic leukaemia using next‐generation flow cytometry in a low/middle‐level income country

Sign Up to like & get
recommendations!
Published in 2022 at "British Journal of Haematology"

DOI: 10.1111/bjh.18499

Abstract: EuroFlow database. 3 In conclusion, NGFlow was effective in minimizing the differences in BCP- ALL MRD results observed in Brazil, with the sensitivity and accuracy necessary for clinical applicability. The strategies used here can be… read more here.

Keywords: standardization minimal; measurable residual; multicentric standardization; minimal measurable ... See more keywords